Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 3
1944 1
1946 2
1947 2
1965 1
1971 1
1972 1
1973 2
1974 1
1975 1
1976 3
1977 2
1979 2
1980 1
1981 1
1982 4
1983 1
1984 1
1986 1
1987 1
1988 1
2007 2
2010 1
2011 1
2012 3
2013 3
2014 1
2015 1
2016 1
2017 2
2018 3
2020 3
2021 5
2022 8
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Cerebrospinal fluid protein biomarkers in Parkinson's disease.
Faizan M, Sachan N, Verma O, Sarkar A, Rawat N, Pratap Singh M. Faizan M, et al. Among authors: verma o. Clin Chim Acta. 2024 Mar 15;556:117848. doi: 10.1016/j.cca.2024.117848. Epub 2024 Feb 27. Clin Chim Acta. 2024. PMID: 38417781 Review.
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Upadhyaya HP, Chien JY, Long AJ, Bohm MS, Kallewaard NL, Macpherson LF, Patel DR, Hufford MM, Krull CJ, Ang JY, Chen P, Muller WJ, Potts JA, Quinn T, Williams M; BLAZE-1 Investigators. Upadhyaya HP, et al. Infect Dis Ther. 2023 Jul;12(7):1861-1873. doi: 10.1007/s40121-023-00832-y. Epub 2023 Jun 17. Infect Dis Ther. 2023. PMID: 37329415 Free PMC article.
Bioactive Molecules Derived from Plants in Managing Dengue Vector Aedes aegypti (Linn.).
Priya SS, Vasantha-Srinivasan P, Altemimi AB, Keerthana R, Radhakrishnan N, Senthil-Nathan S, Kalaivani K, Chandrasekar N, Karthi S, Ganesan R, Alkanan ZT, Pal T, Verma OP, Proćków J. Priya SS, et al. Among authors: verma op. Molecules. 2023 Mar 5;28(5):2386. doi: 10.3390/molecules28052386. Molecules. 2023. PMID: 36903635 Free PMC article. Review.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Portal-Celhay C, Forleo-Neto E, Eagan W, Musser BJ, Davis JD, Turner KC, Norton T, Hooper AT, Hamilton JD, Pan C, Mahmood A, Baum A, Kyratsous CA, Kim Y, Parrino J, Kampman W, Roque-Guerrero L, Stoici R, Fatakia A, Soo Y, Geba GP, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; COVID-19 Phase 2 Dose-Ranging Study Team. Portal-Celhay C, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2225411. doi: 10.1001/jamanetworkopen.2022.25411. JAMA Netw Open. 2022. PMID: 35969402 Free PMC article. Clinical Trial.
69 results